NASDAQ:DCTH (Delcath Systems)

About DCTH

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded in August 1988 and is headquartered in New York, NY.
  • Delcath Systems (NASDAQ: DCTH) Latest News

    No posts found.